Accession Number:

ADA560647

Title:

Development of a Novel NMR-based Rheb GTPase Assay and Molecular Characterization of TSC2 GAP Activity

Descriptive Note:

Revised final rept. 1 May 2009-30 Apr 2010

Corporate Author:

UNIVERSITY HEALTH NETWORK TORONTO (ONTARIO)

Personal Author(s):

Report Date:

2010-05-01

Pagination or Media Count:

31.0

Abstract:

The biological activity of the tuberous sclerosis 12 complex TSC1TSC2, key molecules in the etiology of tuberous sclerosis, is sensitive to a number of homeostatic signals within the cell, including cellular energy levels, availability of oxygen and nutrients and growth factor stimulation. Mechanistically, TSC1 appears to protect TSC2 from proteolytic degradation, whereas TSC2 possesses GTPase activating protein GAP activity towards a small GTPase from the Ras superfamily named Rheb. We hypothesized that nuclear magnetic resonance NMR could be used to monitor Rheb s guanine nucleotide-dependent Rheb s structural changes, in real time, to provide a dynamic readout of its intrinsic and stimulated GTPase activity. Based on these principles we developed a real-time NMR-based GTPase assay which allows unprecedented insight into the molecular mechanism of action of GTPases and implemented it to characterize the molecular mechanism of GTP catalysis by Rheb and the impact of the TSC2 GAP activity on this process. Further, we characterized a series of TSC2 GAP domain mutants found in patients with tuberous sclerosis and determined the molecular mechanism of action of the TSC2 GAP activity on Rheb.

Subject Categories:

  • Biochemistry
  • Medicine and Medical Research

Distribution Statement:

APPROVED FOR PUBLIC RELEASE